Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma.

Ojha R, Leli NM, Onorati A, Piao S, Verginadis II, Tameire F, Rebecca VW, Chude CI, Murugan S, Fennelly C, Noguera-Ortega E, Liu S, Xu X, Krepler C, Xiao M, Xu W, Wei Z, Frederick DT, Boland G, Mitchell TC, Karakousis GC, Schuchter LM, Flaherty KT, Zhang G, Herlyn M, Koumenis C, Amaravadi RK.

Cancer Discov. 2018 Dec 18. pii: CD-18-0348. doi: 10.1158/2159-8290.CD-18-0348. [Epub ahead of print]

PMID:
30563872
2.

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.

Lai MJ, Ojha R, Lin MH, Liu YM, Lee HY, Lin TE, Hsu KC, Chang CY, Chen MC, Nepali K, Chang JY, Liou JP.

Eur J Med Chem. 2019 Jan 15;162:612-630. doi: 10.1016/j.ejmech.2018.10.066. Epub 2018 Nov 3.

PMID:
30476825
3.

PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer.

Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E, Martorella A, Alicea GM, Lee JJ, Schuchter LM, Xu X, Herlyn M, Marmorstein R, Gimotty PA, Speicher DW, Winkler JD, Amaravadi RK.

Cancer Discov. 2018 Nov 15. pii: CD-18-0706. doi: 10.1158/2159-8290.CD-18-0706. [Epub ahead of print]

PMID:
30442709
4.

Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T-lymphotropic virus-1 infection.

Pandey RK, Ojha R, Chatterjee N, Upadhyay N, Mishra A, Prajapati VK.

J Cell Physiol. 2018 Oct 28. doi: 10.1002/jcp.27531. [Epub ahead of print]

PMID:
30370533
5.

Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy.

Ojha R, Nandani R, Prajapati VK.

J Cell Physiol. 2018 Oct 26. doi: 10.1002/jcp.27380. [Epub ahead of print]

PMID:
30362500
6.

Emerging Role of Circular RNAs as Potential Biomarkers for the Diagnosis of Human Diseases.

Ojha R, Nandani R, Chatterjee N, Prajapati VK.

Adv Exp Med Biol. 2018;1087:141-157. doi: 10.1007/978-981-13-1426-1_12.

PMID:
30259364
7.

Symptomatic Extreme Elevation of Prolactin Related to Risperidone Use.

Kc Y, Baldridge HM, Ojha R.

Prim Care Companion CNS Disord. 2018 Sep 20;20(5). pii: 17l02208. doi: 10.4088/PCC.17l02208. No abstract available.

8.

Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.

Khatoon N, Ojha R, Mishra A, Prajapati VK.

Vaccine. 2018 Oct 8;36(42):6290-6300. doi: 10.1016/j.vaccine.2018.09.004. Epub 2018 Sep 11.

PMID:
30217522
9.

Lifestyle factors and health-related quality of life in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study.

Zhang FF, Hudson MM, Huang IC, Bhakta N, Ness KK, Brinkman TM, Klosky J, Lu L, Chen F, Ojha RP, Lanctot JQ, Robison LL, Krull KR.

Cancer. 2018 Oct 1;124(19):3918-3923. doi: 10.1002/cncr.31647. Epub 2018 Sep 11.

PMID:
30204245
10.

Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.

Chauhan A, Bhattacharyya S, Ojha R, Mandal AK, Singh SK.

J Cancer Res Ther. 2018 Jul-Sep;14(5):977-982. doi: 10.4103/jcrt.JCRT_942_15.

11.

Emerging role of circulating microRNA in the diagnosis of human infectious diseases.

Ojha R, Nandani R, Pandey RK, Mishra A, Prajapati VK.

J Cell Physiol. 2019 Feb;234(2):1030-1043. doi: 10.1002/jcp.27127. Epub 2018 Aug 26. Review.

PMID:
30146762
12.

Potential Overestimation of Racial Disparities in Response to the 8-Week Ledipasvir/Sofosbuvir Regimen for Hepatitis C Virus Genotype 1 Infection.

Ojha RP, MacDonald BR, Chu TC, Marcus JL.

Gastroenterology. 2018 Nov;155(5):1646-1647.e2. doi: 10.1053/j.gastro.2018.07.044. Epub 2018 Aug 15. No abstract available.

PMID:
30118741
13.

Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins.

Khatoon N, Pandey RK, Ojha R, Aathmanathan VS, Krishnan M, Prajapati VK.

J Biomol Struct Dyn. 2018 Jul 26:1-42. doi: 10.1080/07391102.2018.1484815. [Epub ahead of print]

PMID:
30047323
14.

Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.

Stewart RA, MacDonald BR, Chu TC, Moore JD, Fasanmi EO, Ojha RP.

Dig Dis Sci. 2018 Dec;63(12):3233-3240. doi: 10.1007/s10620-018-5205-2. Epub 2018 Jul 16.

15.

Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection.

Ojha RP, MacDonald BR, Chu TC, Fasanmi EO, Moore JD, Stewart RA.

Antivir Ther. 2018;23(7):585-592. doi: 10.3851/IMP3249. Epub 2018 Jul 3.

PMID:
29969099
16.

Conglomeration of novel Culex quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections caused by blood imbibing transmitter.

Ojha R, Khatoon N, Prajapati VK.

Int J Biol Macromol. 2018 Oct 15;118(Pt A):834-843. doi: 10.1016/j.ijbiomac.2018.06.112. Epub 2018 Jun 25.

PMID:
29953889
17.

Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection.

Pandey RK, Ali M, Ojha R, Bhatt TK, Prajapati VK.

Vaccine. 2018 Jul 16;36(30):4555-4565. doi: 10.1016/j.vaccine.2018.05.082. Epub 2018 Jun 18.

PMID:
29921492
18.

Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches.

Chatterjee N, Ojha R, Khatoon N, Prajapati VK.

Int J Biol Macromol. 2018 Oct 15;118(Pt A):180-188. doi: 10.1016/j.ijbiomac.2018.06.080. Epub 2018 Jun 18.

PMID:
29920369
19.

Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.

Kumar Pandey R, Ojha R, Mishra A, Kumar Prajapati V.

J Cell Biochem. 2018 Sep;119(9):7631-7642. doi: 10.1002/jcb.27110. Epub 2018 Jun 14.

PMID:
29900580
20.

Real-world data on antiviral treatments for hepatitis C virus infections: Can we define intention to treat or per protocol analyses?

Ojha RP, Steyerberg EW.

J Hepatol. 2018 Aug;69(2):551-553. doi: 10.1016/j.jhep.2018.02.037. Epub 2018 May 26. No abstract available.

PMID:
29843905
21.

Chemical system biology based molecular interactions to identify inhibitors against Q151M mutant of HIV-1 reverse transcriptase.

Pandey RK, Sharma D, Ojha R, Bhatt TK, Prajapati VK.

Infect Genet Evol. 2018 Sep;63:5-12. doi: 10.1016/j.meegid.2018.05.005. Epub 2018 May 9.

PMID:
29753024
22.

Targeting autophagy in cancer.

Onorati AV, Dyczynski M, Ojha R, Amaravadi RK.

Cancer. 2018 Aug;124(16):3307-3318. doi: 10.1002/cncr.31335. Epub 2018 Apr 19. Review.

PMID:
29671878
23.

Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection.

Pandey RK, Ojha R, Aathmanathan VS, Krishnan M, Prajapati VK.

Vaccine. 2018 Apr 19;36(17):2262-2272. doi: 10.1016/j.vaccine.2018.03.042. Epub 2018 Mar 20.

PMID:
29571972
24.

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.

Ojha R, Huang HL, HuangFu WC, Wu YW, Nepali K, Lai MJ, Su CJ, Sung TY, Chen YL, Pan SL, Liou JP.

Eur J Med Chem. 2018 Apr 25;150:667-677. doi: 10.1016/j.ejmech.2018.03.006. Epub 2018 Mar 5.

PMID:
29567459
25.

Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model.

Ojha RP, Asdahl PH, Steyerberg EW, Schroeder H.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26935. Epub 2017 Dec 29.

PMID:
29286572
26.

Measuring childhood cancer late effects: evidence of a healthy survivor effect.

Asdahl PH, Ojha RP, Winther JF, Holmqvist AS, de Fine Licht S, Gudmundsdottir T, Madanat-Harjuoja L, Tryggvadottir L, Andersen KK, Hasle H; ALiCCS study group.

Eur J Epidemiol. 2017 Dec;32(12):1089-1096. doi: 10.1007/s10654-017-0305-4. Epub 2017 Nov 28.

PMID:
29185125
27.

Participation and retention can be high in randomized controlled trials targeting underserved populations: a systematic review and meta-analysis.

Ojha RP, Jackson BE, Lu Y, Burton M, Blair SE, MacDonald BR, Chu TC, Teigen KJ, Acosta M.

J Clin Epidemiol. 2018 Jun;98:154-157. doi: 10.1016/j.jclinepi.2017.11.014. Epub 2017 Nov 26. No abstract available.

PMID:
29183689
28.

Different Cutpoints for Transient Elastography Lead to Different Associations With Cirrhosis.

Ojha RP, MacDonald BR, Chu TC, Greenland S.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1359-1360. doi: 10.1016/j.cgh.2017.11.032. Epub 2017 Nov 22. No abstract available.

PMID:
29174788
29.

Homogenous Dispersion of MoS2 Nanosheets in Polyindole Matrix at Air-Water Interface Assisted by Langmuir Technique.

Mishra R, Nirala NR, Pandey RK, Ojha RP, Prakash R.

Langmuir. 2017 Nov 28;33(47):13572-13580. doi: 10.1021/acs.langmuir.7b03019. Epub 2017 Nov 13.

PMID:
29099604
30.

ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.

Piao S, Ojha R, Rebecca VW, Samanta A, Ma XH, Mcafee Q, Nicastri MC, Buckley M, Brown E, Winkler JD, Gimotty PA, Amaravadi RK.

Autophagy. 2017;13(12):2056-2071. doi: 10.1080/15548627.2017.1377377. Epub 2017 Oct 5.

31.

A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.

Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, Zhang G, Alicea GM, Piao S, Murugan S, Ojha R, Levi SM, Wei Z, Barber-Rotenberg JS, Murphy ME, Mills GB, Lu Y, Rabinowitz J, Marmorstein R, Liu Q, Liu S, Xu X, Herlyn M, Zoncu R, Brady DC, Speicher DW, Winkler JD, Amaravadi RK.

Cancer Discov. 2017 Nov;7(11):1266-1283. doi: 10.1158/2159-8290.CD-17-0741. Epub 2017 Sep 12.

32.

The effect of health insurance on childhood cancer survival in the United States.

Lee JM, Wang X, Ojha RP, Johnson KJ.

Cancer. 2017 Dec 15;123(24):4878-4885. doi: 10.1002/cncr.30925. Epub 2017 Sep 11.

33.

Cancer Screening in Li-Fraumeni Syndrome.

Asdahl PH, Ojha RP, Hasle H.

JAMA Oncol. 2017 Dec 1;3(12):1645-1646. doi: 10.1001/jamaoncol.2017.2459. No abstract available.

PMID:
28772307
34.

Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.

Studaway A, Ojha RP, Brinkman TM, Zhang N, Baassiri M, Banerjee P, Ehrhardt MJ, Srivastava D, Robison LL, Hudson MM, Krull KR.

Cancer. 2017 Nov 15;123(22):4498-4505. doi: 10.1002/cncr.30913. Epub 2017 Jul 25.

35.

Optimal Measurement Interval for Emergency Department Crowding Estimation Tools.

Wang H, Ojha RP, Robinson RD, Jackson BE, Shaikh SA, Cowden CD, Shyamanand R, Leuck J, Schrader CD, Zenarosa NR.

Ann Emerg Med. 2017 Nov;70(5):632-639.e4. doi: 10.1016/j.annemergmed.2017.04.012. Epub 2017 Jul 6.

PMID:
28688771
36.

Proteomic analysis and comparison of intra‑ and extracranial cerebral atherosclerosis responses to hyperlipidemia in rabbits.

Tu ZL, Yu B, Huang DY, Ojha R, Zhou SK, An HD, Liu R, Du C, Shen N, Fu JH, Hou SX.

Mol Med Rep. 2017 Sep;16(3):2347-2354. doi: 10.3892/mmr.2017.6869. Epub 2017 Jun 28.

37.

A school-based intervention of screening a movie to increase hepatitis B vaccination levels among students in Uttar Pradesh, India: impact on knowledge, awareness, attitudes and vaccination levels.

Choudhuri G, Ojha R, Negi TS, Gupta V, Saxena S, Choudhuri A, Pal S, Choudhuri J, Sangam A.

Hepatol Med Policy. 2017 Jun 13;2:10. doi: 10.1186/s41124-017-0027-y. eCollection 2017. Erratum in: Hepatol Med Policy. 2018 Sep 14;3:11.

38.

Erratum: Temporal expression profiling of novel Spodoptera litura nucleopolyhedrovirus-encoded microRNAs upon infection of Sf21 cells.

Kharbanda N, Jalali SK, Ojha R, Bhatnagar RK.

J Gen Virol. 2017 May;98(5):1142. doi: 10.1099/jgv.0.000820. No abstract available.

PMID:
28581382
39.

Whole genome sequence and comparative genomic sequence analysis of Helicoverpa armigera nucleopolyhedrovirus (HearNPV-L1) isolated from India.

Raghavendra AT, Jalali SK, Ojha R, Shivalingaswamy TM, Bhatnagar R.

Virusdisease. 2017 Mar;28(1):61-68. doi: 10.1007/s13337-016-0352-6. Epub 2017 Feb 13.

40.

The role of body image dissatisfaction in the association between treatment-related scarring or disfigurement and psychological distress in adult survivors of childhood cancer.

Vuotto SC, Ojha RP, Li C, Kimberg C, Klosky JL, Krull KR, Srivastava DK, Robison LL, Hudson MM, Brinkman TM.

Psychooncology. 2018 Jan;27(1):216-222. doi: 10.1002/pon.4439. Epub 2017 May 31.

41.

Targeting the unfolded protein response in cancer.

Ojha R, Amaravadi RK.

Pharmacol Res. 2017 Jun;120:258-266. doi: 10.1016/j.phrs.2017.04.003. Epub 2017 Apr 8. Review.

42.

Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway.

Chauhan A, Ojha R, Semwal DK, Mishra SP, Semwal RB.

Anticancer Agents Med Chem. 2017 Nov 24;17(11):1545-1554. doi: 10.2174/1871520617666170213111002.

PMID:
28270077
43.

Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.

Dubey KD, Tiwari G, Ojha RP.

J Mol Model. 2017 Apr;23(4):102. doi: 10.1007/s00894-017-3259-2. Epub 2017 Mar 2.

PMID:
28255859
44.

Congenital facial nerve aplasia: MR depiction of a rare anomaly.

Kumar I, Verma A, Ojha R, Aggarwal P.

Indian J Radiol Imaging. 2016 Oct-Dec;26(4):517-520. doi: 10.4103/0971-3026.195791.

45.

Factors supporting cardiomyopathy screening among at-risk adult survivors of pediatric malignancies.

Cox CL, Zhu L, Ojha RP, Steen BD, Ogg S, Robison LL, Hudson MM.

Support Care Cancer. 2017 Apr;25(4):1307-1316. doi: 10.1007/s00520-016-3530-6. Epub 2016 Dec 30.

46.

Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.

Nepali K, Lee HY, Lai MJ, Ojha R, Wu TY, Wu GX, Chen MC, Liou JP.

Eur J Med Chem. 2017 Feb 15;127:115-127. doi: 10.1016/j.ejmech.2016.12.039. Epub 2016 Dec 21.

PMID:
28038324
47.

Magnetic resonance neurographic confirmation of extensive Plexiform neurofibroma in neurofibromatosis-1 presenting as ambiguous genitalia.

Kumar I, Verma A, Ojha R, Aggarwal P, Shukla RC, Srivastava A.

Indian J Radiol Imaging. 2016 Jul-Sep;26(3):332-336.

48.

An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015).

Ojha R, Singh J, Ojha A, Singh H, Sharma S, Nepali K.

Expert Opin Ther Pat. 2017 Mar;27(3):311-345. doi: 10.1080/13543776.2017.1261111. Epub 2016 Nov 28. Review.

PMID:
27841045
49.

Adult Survivors of Childhood Cancer Have Poor Adherence to Dietary Guidelines.

Zhang FF, Ojha RP, Krull KR, Gibson TM, Lu L, Lanctot J, Chemaitilly W, Robison LL, Hudson MM.

J Nutr. 2016 Dec;146(12):2497-2505. Epub 2016 Oct 19.

50.

Menkes disease: what a multidisciplinary approach can do.

Ojha R, Prasad AN.

J Multidiscip Healthc. 2016 Aug 17;9:371-85. doi: 10.2147/JMDH.S93454. eCollection 2016. Review.

Supplemental Content

Support Center